祝您天天发财

讨论

我刚刚关注了雪球组合 $蹊之生物医药精选(ZH1313402)$ ，当前净值2.1250。

讨论

我刚刚关注了雪球话题 #2020春节见闻# 欢迎一起来讨论

讨论

看好音乐付费市场。 不说原因直接歪个题吧。朋友圈刷屏 晕 ！“说好不哭” 说的啥 ？朋友圈都人母中年 至于泪流满面的？ 这mv 简直是毒害年轻人啊。你啥都没有 拿什么为别人的梦想加油买单？先好好善待充实自己吧。 没爱情很好 有爱情一起努力更好 网页链接

讨论

网页链接

讨论

~•~•~

讨论

这个写得很好 这个人懂啊
Amarin's REDUCE-IT Trial: Something Fishy?
by DoctoRx
渐渐地发现 许多人只是不断重复别人的观点来证明自己的智慧 唉+唉

讨论

感谢·所有在我投机投资路上帮助过我的老师们。
不打扰·是我现在能做的祝福你们的唯一方式。
教师节快乐！ 感恩节快乐！圣诞节快乐！新年快乐！每一天都快乐！

讨论

转发

讨论

回复@不明真相的群众: 说得好
雪球 应该 除了可以 thumb up 赞 每个帖子 ， 再加上 thumb down 不赞成 帖子的功能。其它网都有的， 就是不想说话 点一下 表个态之类的，这样看看有些粉丝是为啥关注大v 了//@不明真相的群众:回复@黄建平:你对世界品头论足，别人对你品头论足，你没...

讨论

请你注明你有些帖子的 出处，你可以引用， 但是先给个链接 说明原出处。 这样 既尊重原作者，也尊重读者 （避免我们浪费时间反复读同一news）。thx

讨论

陈老师的文章写的太好了 偏偏锦绣 字字珠玑！把这些组成系列篇章 可以印书了

讨论

mdco
MDCO The Medicines Co presents new data from its TANGO II study of VABOMERE at IDWeek 2017 (38.27 )
In the TANGO II study, VABOMERE was associated with a higher clinical cure versus "best available therapy" (BAT) in patients with a baseline organism that ...

讨论

$Arbutus Biopharma Corporation(ABUS)$
Arbutus Biopharma indicated higher after detailing plans to present HBV Data at upcoming conferences (6.55 -0.45)
Discovery on Target: Targeting HBV, Sept 25 Presentations Include: RNA Interference: A New Tool in the Toolbox for...

讨论

OCX OncoCyte presents 'positive' final results from the Analytical Validation Study of its liquid biopsy lung cancer diagnostic test, DetermaVU (6.55 )
The accuracy results of the Analytical Validation Study reported today demonstrate sensitivity of 94.4%, specifi...

讨论

AEMD Aethlon Medical has received EAP designation from the FDA to support the advancement of the Aethlon Hemopurifier (1.99 )
"We are honored to have our Hemopurifier designated to the Expedited Access Pathway and additionally are pleased that FDA has also allowed our...

讨论

RARE Ultragenyx Pharma and Kyowa Hakko Kirin Co. announce positive data from two ongoing Phase 2 studies - 40 week data from the study in children less than five years old with X-linked hypophosphatemia and 24 week data from the study in adult tumor-induced osteomalacia patie...

讨论

CYTK Cytokinetics announces results from COSMIC-HF Phase 2 trials will be presented in a Rapid Fire Abstracts Presentation at the 21st Annual Heart Failure Society of America Scientific Meeting from September 16-19 in Dallas, TX (14.70 +0.00)

讨论

AMGN Amgen announces results from the Phase 3 ARCH study (186.49 +5.85)
Amgen (AMGN) and UCB announced detailed results from the Phase 3 ARCH study showing that 12 months of EVENITY (romosozumab) followed by alendronate was superior in reducing new vertebral, clinical, no...